Abnormal thyroid hormone receptor function is often associated with some forms of human disease. Thyroid hormone receptor responds to circulating thyroid hormone and through interactions with its cognate DNA binding elements, changes in gene expression ensue. In addition to thyroid hormone receptor co-repressor and co-activator proteins. Together with the thyroid hormone receptor, these help to form protein DNA complexes, which alter gene transcription. The thyroid hormone receptor is made of two domains, one that binds DNA and one that binds hormone. Our interest is in understanding the structure and response of the receptor to binding protein partners and thyroid hormone or its analogs. Though they would be medically important, no antagonists of thyroid hormone receptor are known. Identification and synthesis of thyroid hormone antagonists would provide tools for understanding the normal and abnormal response of the thyroid hormone antagonists would provide tools for understanding the normal and abnormal response of the thyroid hormone receptors. We will determine the structural and the dynamic response of thyroid hormone receptor to binding partners of the hormone- binding domain by NMR and X-ray crystallography. Antagonists for thyroid hormone and antagonists for co-activator for co-activator binding will be identified. These molecules could have therapeutic value in human disease or become useful biological tools.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK058390-03
Application #
6618177
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Shiau, Andrew K; Harris, Seth F; Southworth, Daniel R et al. (2006) Structural Analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell 127:329-40
Ota, Nobuyuki; Agard, David A (2005) Intramolecular signaling pathways revealed by modeling anisotropic thermal diffusion. J Mol Biol 351:345-54
Moore, Jamie M R; Galicia, Sarah J; McReynolds, Andrea C et al. (2004) Quantitative proteomics of the thyroid hormone receptor-coregulator interactions. J Biol Chem 279:27584-90
Sandler, Ben; Webb, Paul; Apriletti, James W et al. (2004) Thyroxine-thyroid hormone receptor interactions. J Biol Chem 279:55801-8
Harris, Seth F; Shiau, Andrew K; Agard, David A (2004) The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site. Structure 12:1087-97
Huber, B Russell; Desclozeaux, Marion; West, Brian L et al. (2003) Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domain. Mol Endocrinol 17:107-16
Sablin, Elena P; Krylova, Irina N; Fletterick, Robert J et al. (2003) Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol Cell 11:1575-85
Borngraeber, Sabine; Budny, Mary-Jane; Chiellini, Grazia et al. (2003) Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor. Proc Natl Acad Sci U S A 100:15358-63
Kelly, Alexander E; Ou, Horng D; Withers, Richard et al. (2002) Low-conductivity buffers for high-sensitivity NMR measurements. J Am Chem Soc 124:12013-9